 | • レポートコード：QYR2104Z2547 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん治療におけるゲノミクスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、サービス）、用途別市場規模（診断、個別化医療、創薬、開発、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん治療におけるゲノミクスの市場動向 ・企業の競争状況、市場シェア ・がん治療におけるゲノミクスの種類別市場規模（機器、消耗品、サービス） ・がん治療におけるゲノミクスの用途別市場規模（診断、個別化医療、創薬、開発、研究） ・がん治療におけるゲノミクスの北米市場規模2016-2027（アメリカ、カナダ） ・がん治療におけるゲノミクスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん治療におけるゲノミクスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん治療におけるゲノミクスの中南米市場規模2016-2027（メキシコ、ブラジル） ・がん治療におけるゲノミクスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Illumina、Thermo Fisher scientific、Agilent、Roche、Cancer Genetics、Beckman Coulter、Bio-Rad、Danaher、Sigma Aldrich、Pacific Biosciences、Quest Diagnostics、Luminex、Oxford Gene Technology、PerkinElmer、Qiagen、GE Healthcare） ・結論 |
Market Analysis and Insights: Global Genomics In Cancer Care Market
The global Genomics In Cancer Care market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genomics In Cancer Care market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genomics In Cancer Care market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genomics In Cancer Care market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genomics In Cancer Care market.
Global Genomics In Cancer Care Scope and Market Size
Genomics In Cancer Care market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genomics In Cancer Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Instruments
Consumables
Services
Segment by Application
Diagnostics
Personalized Medicine
Drug Discovery
Development
Research
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Illumina
Thermo Fisher scientific
Agilent
Roche
Cancer Genetics
Beckman Coulter
Bio-Rad
Danaher
Sigma Aldrich
Roche
Cancer Genetics
Luminex
Oxford Gene Technology
PerkinElmer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2016-2027)
2.2 Genomics In Cancer Care Growth Trends by Regions
2.2.1 Genomics In Cancer Care Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genomics In Cancer Care Historic Market Share by Regions (2016-2021)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Regions (2022-2027)
2.3 Genomics In Cancer Care Industry Dynamic
2.3.1 Genomics In Cancer Care Market Trends
2.3.2 Genomics In Cancer Care Market Drivers
2.3.3 Genomics In Cancer Care Market Challenges
2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Revenue
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2016-2021)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2016-2021)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2020
3.5 Genomics In Cancer Care Key Players Head office and Area Served
3.6 Key Players Genomics In Cancer Care Product Solution and Service
3.7 Date of Enter into Genomics In Cancer Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2016-2021)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2022-2027)
5 Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2016-2021)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2016-2027)
6.2 North America Genomics In Cancer Care Market Size by Type
6.2.1 North America Genomics In Cancer Care Market Size by Type (2016-2021)
6.2.2 North America Genomics In Cancer Care Market Size by Type (2022-2027)
6.2.3 North America Genomics In Cancer Care Market Size by Type (2016-2027)
6.3 North America Genomics In Cancer Care Market Size by Application
6.3.1 North America Genomics In Cancer Care Market Size by Application (2016-2021)
6.3.2 North America Genomics In Cancer Care Market Size by Application (2022-2027)
6.3.3 North America Genomics In Cancer Care Market Size by Application (2016-2027)
6.4 North America Genomics In Cancer Care Market Size by Country
6.4.1 North America Genomics In Cancer Care Market Size by Country (2016-2021)
6.4.2 North America Genomics In Cancer Care Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2016-2027)
7.2 Europe Genomics In Cancer Care Market Size by Type
7.2.1 Europe Genomics In Cancer Care Market Size by Type (2016-2021)
7.2.2 Europe Genomics In Cancer Care Market Size by Type (2022-2027)
7.2.3 Europe Genomics In Cancer Care Market Size by Type (2016-2027)
7.3 Europe Genomics In Cancer Care Market Size by Application
7.3.1 Europe Genomics In Cancer Care Market Size by Application (2016-2021)
7.3.2 Europe Genomics In Cancer Care Market Size by Application (2022-2027)
7.3.3 Europe Genomics In Cancer Care Market Size by Application (2016-2027)
7.4 Europe Genomics In Cancer Care Market Size by Country
7.4.1 Europe Genomics In Cancer Care Market Size by Country (2016-2021)
7.4.2 Europe Genomics In Cancer Care Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Genomics In Cancer Care Market Size (2016-2027)
8.2 Asia-Pacific Genomics In Cancer Care Market Size by Type
8.2.1 Asia-Pacific Genomics In Cancer Care Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genomics In Cancer Care Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genomics In Cancer Care Market Size by Type (2016-2027)
8.3 Asia-Pacific Genomics In Cancer Care Market Size by Application
8.3.1 Asia-Pacific Genomics In Cancer Care Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genomics In Cancer Care Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genomics In Cancer Care Market Size by Application (2016-2027)
8.4 Asia-Pacific Genomics In Cancer Care Market Size by Region
8.4.1 Asia-Pacific Genomics In Cancer Care Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genomics In Cancer Care Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Genomics In Cancer Care Market Size (2016-2027)
9.2 Latin America Genomics In Cancer Care Market Size by Type
9.2.1 Latin America Genomics In Cancer Care Market Size by Type (2016-2021)
9.2.2 Latin America Genomics In Cancer Care Market Size by Type (2022-2027)
9.2.3 Latin America Genomics In Cancer Care Market Size by Type (2016-2027)
9.3 Latin America Genomics In Cancer Care Market Size by Application
9.3.1 Latin America Genomics In Cancer Care Market Size by Application (2016-2021)
9.3.2 Latin America Genomics In Cancer Care Market Size by Application (2022-2027)
9.3.3 Latin America Genomics In Cancer Care Market Size by Application (2016-2027)
9.4 Latin America Genomics In Cancer Care Market Size by Country
9.4.1 Latin America Genomics In Cancer Care Market Size by Country (2016-2021)
9.4.2 Latin America Genomics In Cancer Care Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics In Cancer Care Market Size (2016-2027)
10.2 Middle East & Africa Genomics In Cancer Care Market Size by Type
10.2.1 Middle East & Africa Genomics In Cancer Care Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genomics In Cancer Care Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genomics In Cancer Care Market Size by Type (2016-2027)
10.3 Middle East & Africa Genomics In Cancer Care Market Size by Application
10.3.1 Middle East & Africa Genomics In Cancer Care Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genomics In Cancer Care Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genomics In Cancer Care Market Size by Application (2016-2027)
10.4 Middle East & Africa Genomics In Cancer Care Market Size by Country
10.4.1 Middle East & Africa Genomics In Cancer Care Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genomics In Cancer Care Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Introduction
11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Details
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2016-2021)
11.2.5 Thermo Fisher scientific Recent Development
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Introduction
11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2016-2021)
11.3.5 Agilent Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Introduction
11.4.4 Roche Revenue in Genomics In Cancer Care Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2016-2021)
11.5.5 Cancer Genetics Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2016-2021)
11.6.5 Beckman Coulter Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Introduction
11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2016-2021)
11.7.5 Bio-Rad Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Introduction
11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2016-2021)
11.8.5 Danaher Recent Development
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2016-2021)
11.9.5 Sigma Aldrich Recent Development
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Details
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2016-2021)
11.10.5 Pacific Biosciences Recent Development
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Details
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2016-2021)
11.11.5 Quest Diagnostics Recent Development
11.12 Luminex
11.12.1 Luminex Company Details
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Introduction
11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2016-2021)
11.12.5 Luminex Recent Development
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Details
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2016-2021)
11.13.5 Oxford Gene Technology Recent Development
11.14 PerkinElmer
11.14.1 PerkinElmer Company Details
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Introduction
11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2016-2021)
11.14.5 PerkinElmer Recent Development
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Introduction
11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2016-2021)
11.15.5 Qiagen Recent Development
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Introduction
11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2016-2021)
11.16.5 GE Healthcare Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Key Players of Services
Table 5. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Genomics In Cancer Care Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Genomics In Cancer Care Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Genomics In Cancer Care Market Share by Regions (2016-2021)
Table 9. Global Genomics In Cancer Care Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Genomics In Cancer Care Market Share by Regions (2022-2027)
Table 11. Genomics In Cancer Care Market Trends
Table 12. Genomics In Cancer Care Market Drivers
Table 13. Genomics In Cancer Care Market Challenges
Table 14. Genomics In Cancer Care Market Restraints
Table 15. Global Genomics In Cancer Care Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Genomics In Cancer Care Market Share by Players (2016-2021)
Table 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2020)
Table 18. Ranking of Global Top Genomics In Cancer Care Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genomics In Cancer Care Product Solution and Service
Table 22. Date of Enter into Genomics In Cancer Care Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomics In Cancer Care Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2016-2021)
Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Genomics In Cancer Care Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Genomics In Cancer Care Revenue Market Share by Application (2016-2021)
Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Genomics In Cancer Care Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Genomics In Cancer Care Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Genomics In Cancer Care Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Genomics In Cancer Care Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Genomics In Cancer Care Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Genomics In Cancer Care Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Genomics In Cancer Care Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Genomics In Cancer Care Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Genomics In Cancer Care Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Genomics In Cancer Care Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Genomics In Cancer Care Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Genomics In Cancer Care Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Genomics In Cancer Care Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Genomics In Cancer Care Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Genomics In Cancer Care Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Genomics In Cancer Care Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Genomics In Cancer Care Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Genomics In Cancer Care Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Genomics In Cancer Care Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Genomics In Cancer Care Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Genomics In Cancer Care Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Genomics In Cancer Care Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Genomics In Cancer Care Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Genomics In Cancer Care Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Genomics In Cancer Care Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Genomics In Cancer Care Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Genomics In Cancer Care Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Genomics In Cancer Care Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Genomics In Cancer Care Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Genomics In Cancer Care Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Genomics In Cancer Care Market Size by Country (2022-2027) & (US$ Million)
Table 62. Illumina Company Details
Table 63. Illumina Business Overview
Table 64. Illumina Genomics In Cancer Care Product
Table 65. Illumina Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 66. Illumina Recent Development
Table 67. Thermo Fisher scientific Company Details
Table 68. Thermo Fisher scientific Business Overview
Table 69. Thermo Fisher scientific Genomics In Cancer Care Product
Table 70. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher scientific Recent Development
Table 72. Agilent Company Details
Table 73. Agilent Business Overview
Table 74. Agilent Genomics In Cancer Care Product
Table 75. Agilent Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 76. Agilent Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Genomics In Cancer Care Product
Table 80. Roche Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Cancer Genetics Company Details
Table 83. Cancer Genetics Business Overview
Table 84. Cancer Genetics Genomics In Cancer Care Product
Table 85. Cancer Genetics Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 86. Cancer Genetics Recent Development
Table 87. Beckman Coulter Company Details
Table 88. Beckman Coulter Business Overview
Table 89. Beckman Coulter Genomics In Cancer Care Product
Table 90. Beckman Coulter Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 91. Beckman Coulter Recent Development
Table 92. Bio-Rad Company Details
Table 93. Bio-Rad Business Overview
Table 94. Bio-Rad Genomics In Cancer Care Product
Table 95. Bio-Rad Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 96. Bio-Rad Recent Development
Table 97. Danaher Company Details
Table 98. Danaher Business Overview
Table 99. Danaher Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 100. Danaher Recent Development
Table 101. Sigma Aldrich Company Details
Table 102. Sigma Aldrich Business Overview
Table 103. Sigma Aldrich Genomics In Cancer Care Product
Table 104. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 105. Sigma Aldrich Recent Development
Table 106. Pacific Biosciences Company Details
Table 107. Pacific Biosciences Business Overview
Table 108. Pacific Biosciences Genomics In Cancer Care Product
Table 109. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 110. Pacific Biosciences Recent Development
Table 111. Quest Diagnostics Company Details
Table 112. Quest Diagnostics Business Overview
Table 113. Quest Diagnostics Genomics In Cancer Care Product
Table 114. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 115. Quest Diagnostics Recent Development
Table 116. Luminex Company Details
Table 117. Luminex Business Overview
Table 118. Luminex Genomics In Cancer Care Product
Table 119. Luminex Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 120. Luminex Recent Development
Table 121. Oxford Gene Technology Company Details
Table 122. Oxford Gene Technology Business Overview
Table 123. Oxford Gene Technology Genomics In Cancer Care Product
Table 124. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 125. Oxford Gene Technology Recent Development
Table 126. PerkinElmer Company Details
Table 127. PerkinElmer Business Overview
Table 128. PerkinElmer Genomics In Cancer Care Product
Table 129. PerkinElmer Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 130. PerkinElmer Recent Development
Table 131. Qiagen Company Details
Table 132. Qiagen Business Overview
Table 133. Qiagen Genomics In Cancer Care Product
Table 134. Qiagen Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 135. Qiagen Recent Development
Table 136. GE Healthcare Company Details
Table 137. GE Healthcare Business Overview
Table 138. GE Healthcare Genomics In Cancer Care Product
Table 139. GE Healthcare Revenue in Genomics In Cancer Care Business (2016-2021) & (US$ Million)
Table 140. GE Healthcare Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Market Share by Type: 2020 VS 2027
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Services Features
Figure 5. Global Genomics In Cancer Care Market Share by Application: 2020 VS 2027
Figure 6. Diagnostics Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Development Case Studies
Figure 10. Research Case Studies
Figure 11. Genomics In Cancer Care Report Years Considered
Figure 12. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Genomics In Cancer Care Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Genomics In Cancer Care Market Share by Regions: 2020 VS 2027
Figure 15. Global Genomics In Cancer Care Market Share by Regions (2022-2027)
Figure 16. Global Genomics In Cancer Care Market Share by Players in 2020
Figure 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2020
Figure 19. Global Genomics In Cancer Care Revenue Market Share by Type (2016-2021)
Figure 20. Global Genomics In Cancer Care Revenue Market Share by Type (2022-2027)
Figure 21. North America Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Genomics In Cancer Care Market Share by Type (2016-2027)
Figure 23. North America Genomics In Cancer Care Market Share by Application (2016-2027)
Figure 24. North America Genomics In Cancer Care Market Share by Country (2016-2027)
Figure 25. United States Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Genomics In Cancer Care Market Share by Type (2016-2027)
Figure 29. Europe Genomics In Cancer Care Market Share by Application (2016-2027)
Figure 30. Europe Genomics In Cancer Care Market Share by Country (2016-2027)
Figure 31. Germany Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Genomics In Cancer Care Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Genomics In Cancer Care Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Genomics In Cancer Care Market Share by Region (2016-2027)
Figure 41. China Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Genomics In Cancer Care Market Share by Type (2016-2027)
Figure 49. Latin America Genomics In Cancer Care Market Share by Application (2016-2027)
Figure 50. Latin America Genomics In Cancer Care Market Share by Country (2016-2027)
Figure 51. Mexico Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Genomics In Cancer Care Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Genomics In Cancer Care Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Genomics In Cancer Care Market Share by Country (2016-2027)
Figure 57. Turkey Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Genomics In Cancer Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 61. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 62. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 64. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 65. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 66. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 67. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 68. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 69. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 70. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 71. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 72. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 73. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 74. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 75. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のゲノミクス市場規模・現状・予測（2021年-2027年） Genomics is the science of studying genomes and their interaction with a variety of stimuli. The global genomics market is chiefly driven by the intensifying level of competition in the global pharmaceutical industry and the increased use of genomics in research and development of new drug classes. …- 世界のゲノミクス市場規模・現状・予測（2021年-2027年） Genomics is the science of studying genomes and their interaction with a variety of stimuli. The global genomics market is chiefly driven by the intensifying level of competition in the global pharmaceutical industry and the increased use of genomics in research and development of new drug classes. …
- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnostics & Therapeutics Market The global Colorectal Cancer Diagnostics & Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…
- 世界のゲノミクス個別化医療市場規模・現状・予測（2021年-2027年） The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in em…
- 世界のゲノミクス個別化医療市場規模・現状・予測（2021年-2027年） The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in em…